Use of a combination of Dbait molecule and PARP inhibitors to treat cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11162095
APP PUB NO 20200172901A1
SERIAL NO

16790788

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the combination of a PARP inhibitor with a Dbait molecule for treating cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VALERIO THERAPEUTICS49 BOULEVARD DU GÉNÉRAL MARTIAL VALIN PARIS 75015

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dutreix, Marie L'Hay-les-Roses, FR 17 56
Jdey, Wael Longjumeau, FR 4 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 May 2, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 May 2, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 2, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00